1. Home
  2. UTHR vs FIX Comparison

UTHR vs FIX Comparison

Compare UTHR & FIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • FIX
  • Stock Information
  • Founded
  • UTHR 1996
  • FIX 1917
  • Country
  • UTHR United States
  • FIX United States
  • Employees
  • UTHR N/A
  • FIX N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • FIX Engineering & Construction
  • Sector
  • UTHR Health Care
  • FIX Industrials
  • Exchange
  • UTHR Nasdaq
  • FIX Nasdaq
  • Market Cap
  • UTHR 14.4B
  • FIX 17.1B
  • IPO Year
  • UTHR 1999
  • FIX 1997
  • Fundamental
  • Price
  • UTHR $297.02
  • FIX $540.34
  • Analyst Decision
  • UTHR Buy
  • FIX Strong Buy
  • Analyst Count
  • UTHR 13
  • FIX 3
  • Target Price
  • UTHR $383.08
  • FIX $595.33
  • AVG Volume (30 Days)
  • UTHR 561.1K
  • FIX 344.4K
  • Earning Date
  • UTHR 07-30-2025
  • FIX 07-24-2025
  • Dividend Yield
  • UTHR N/A
  • FIX 0.34%
  • EPS Growth
  • UTHR 18.86
  • FIX 64.78
  • EPS
  • UTHR 25.10
  • FIX 16.66
  • Revenue
  • UTHR $2,994,100,000.00
  • FIX $7,321,746,000.00
  • Revenue This Year
  • UTHR $14.58
  • FIX $11.66
  • Revenue Next Year
  • UTHR $6.34
  • FIX $6.83
  • P/E Ratio
  • UTHR $11.77
  • FIX $32.38
  • Revenue Growth
  • UTHR 19.84
  • FIX 31.47
  • 52 Week Low
  • UTHR $266.98
  • FIX $272.93
  • 52 Week High
  • UTHR $417.82
  • FIX $553.09
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 51.32
  • FIX 63.94
  • Support Level
  • UTHR $286.68
  • FIX $517.03
  • Resistance Level
  • UTHR $301.75
  • FIX $549.22
  • Average True Range (ATR)
  • UTHR 6.73
  • FIX 15.07
  • MACD
  • UTHR 1.81
  • FIX -0.91
  • Stochastic Oscillator
  • UTHR 77.16
  • FIX 80.33

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About FIX Comfort Systems USA Inc.

Comfort Systems USA Inc provides comprehensive mechanical contracting services, including heating, ventilation, & air conditioning, or HVAC; plumbing; piping & controls; construction; and other electrical components. Projects are mainly for commercial, industrial, & institutional buildings, & tend to be geared toward HVAC. Revenue is roughly split between installation services for newly constructed facilities & maintenance services for existing buildings. The company installs & repairs products and systems throughout the United States. It operates in two segments, Mechanical services & Electrical services, the majority is from the Mechanical services segment.

Share on Social Networks: